Ronald Kirk Huntsman - 23 Dec 2022 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Issuer symbol: VVOS
Transactions as of: 23 Dec 2022
Net transactions value: +$242,000
Form type: 4
Filing time: 28 Dec 2022, 20:45:36 UTC
Previous filing: 03 Jun 2022
Next filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VVOS	Common Stock	Purchase	$10,000	+20,000	+73%	$0.5000	47,500	23 Dec 2022	Direct	F1
holding	VVOS	Common Stock						1,740,000	23 Dec 2022	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VVOS	Stock Option (Right to Buy)	Award	$160,000	+333,334		$0.4800	333,334	23 Dec 2022	Common Stock	333,334	$0.4800	Direct	F2
transaction	VVOS	Stock Option (Right to Buy)	Award	$72,000	+150,000	+45%	$0.4800	483,334	23 Dec 2022	Common Stock	483,334	$0.4800	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
F2	333,334 fully vested stock options granted on December 23, 2022.
F3	150,000 stock options granted on December 23, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through December 23, 2026.